Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Inositol 1,4,5-trisphosphate receptor (IP3R) is a family of ligand-gated intracellular calcium release channels predominantly localized on the membrane of the endoplasmic and sarcoplasmic reticulum. Comprising three distinct mammalian isoforms (IP3R1, IP3R2, and IP3R3), these tetrameric channels open in response to the binding of the second messenger inositol 1,4,5-trisphosphate (IP3) and cytosolic calcium, facilitating the rapid efflux of calcium ions into the cytoplasm. This IP3 receptor-dependent calcium release machinery plays a fundamental role in regulating diverse cellular processes, including signal transduction, gene transcription, cell proliferation, apoptosis, and mitochondrial bioenergetics. Dysregulation of IP3R-mediated calcium signaling is implicated in a wide range of human pathologies, such as neurodegenerative disorders (e.g., spinocerebellar ataxias and Huntington's disease), cardiovascular diseases (e.g., cardiac hypertrophy, heart failure, and arrhythmias), and various cancers where altered IP3R expression supports tumor cell survival and invasion. Pharmacological modulation of IP3Rs represents a promising therapeutic strategy, with research focusing on small-molecule inhibitors like 2-APB, xestospongins, and subtype-selective peptide inhibitors to normalize calcium homeostasis in diseased states. However, the ubiquitous expression of IP3Rs and the lack of highly selective, clinically viable modulators present significant therapeutic challenges and safety concerns.
Inositol 1,4,5-trisphosphate receptor antagonist, agonist, or modulator
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inositol 1,4,5-trisphosphate receptor (IP3R).